Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Clinical trial NCT05275478 · TERMINATED

Trial details

NCT number: NCT05275478
Sponsor: Tango Therapeutics, Inc.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Locally Advanced Solid Tumor

Start date: 2022-03-23
Primary completion: 2025-12-30
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.